Treatment of nonatypical and atypical endometrial hyperplasia with a levonorgestrel-releasing intrauterine system

被引：70
|
作者：
Wildemeersch, D [1 ]
Dhont, M
机构：
[1] Univ Hosp, Gynecol Res Unit, Knokke, Belgium
[2] State Univ Ghent Hosp, Dept Obstet & Gynecol, B-9000 Ghent, Belgium
来源：
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY | 2003年 / 188卷 / 05期
关键词：
frameless in trauterine system; levonorgestrel; endometrial hyperplasia;
D O I：
10.1067/mob.2003.346
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
OBJECTIVE: A "frameless" intrauterine drug delivery system that releases 14 mug/d of levonorgestrel was used to treat nonatypical and atypical endometrial hyperplasia in 12 women. STUDY DESIGN: This noncomparative study had up to 3 to 4 years of follow-up. RESULTS: The cure rate was 100%, as confirmed by repeat endometrial biopsy. CONCLUSION: This method could be considered an alternative to hysterectomy.
引用
收藏
页码：1297 / 1298
页数：2
相关论文
共 50 条
  • [31] Endometrial Cancer Following Levonorgestrel-Releasing Intrauterine System Insertion in Young Women with Atypical Hyperplasia: Two Case Reports and Literature Review
    Hongfa Peng
    Jingjing Jiang
    Xiaodong Li
    Reproductive Sciences, 2022, 29 : 3278 - 3284
  • [32] Mirena - Levonorgestrel-releasing intrauterine system
    不详
    FORMULARY, 2001, 36 (02) : 93 - 93
  • [33] Efficacy of the Levonorgestrel-Releasing Intrauterine System on IVF-ET Outcomes in PCOS With Simple Endometrial Hyperplasia
    Jiang Bian
    Hongfang Shao
    Hua Liu
    Hui Li
    Lu Fang
    Changying Xing
    Lihong Wang
    Minfang Tao
    Reproductive Sciences, 2015, 22 : 758 - 766
  • [34] Endometrial Cancer Following Levonorgestrel-Releasing Intrauterine System Insertion in Young Women with Atypical Hyperplasia: Two Case Reports and Literature Review
    Peng, Hongfa
    Jiang, Jingjing
    Li, Xiaodong
    REPRODUCTIVE SCIENCES, 2022, 29 (11) : 3278 - 3284
  • [35] Efficacy of the Levonorgestrel-Releasing Intrauterine System on IVF-ET Outcomes in PCOS With Simple Endometrial Hyperplasia
    Bian, Jiang
    Shao, Hongfang
    Liu, Hua
    Li, Hui
    Fang, Lu
    Xing, Changying
    Wang, Lihong
    Tao, Minfang
    REPRODUCTIVE SCIENCES, 2015, 22 (06) : 758 - 766
  • [36] Levonorgestrel-releasing intrauterine system vs oral progestins for non-atypical endometrial hyperplasia: a systematic review and metaanalysis of randomized trials
    Abu Hashim, Hatem
    Ghayaty, Essam
    El Rakhawy, Mohamed
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2015, 213 (04) : 469 - 478
  • [37] Levonorgestrel-Releasing Intrauterine Device Versus Dydrogesterone for Management of Endometrial Hyperplasia Without Atypia
    El Behery, Manal M.
    Saleh, Hend S.
    Ibrahiem, Moustafa A.
    Kamal, Ebtesam M.
    Kassem, Gamal A.
    Mohamed, Mohamed El Sayed
    REPRODUCTIVE SCIENCES, 2015, 22 (03) : 329 - 334
  • [38] Levonorgestrel-Releasing Intrauterine Device Versus Dydrogesterone for Management of Endometrial Hyperplasia Without Atypia
    Manal M. El Behery
    Hend S. Saleh
    Moustafa A. Ibrahiem
    Ebtesam M. Kamal
    Gamal A. Kassem
    Mohamed El Sayed Mohamed
    Reproductive Sciences, 2015, 22 : 329 - 334
  • [39] Gonadotropin-Releasing Hormone Agonist Combined With a Levonorgestrel-Releasing Intrauterine System or Letrozole for Fertility-Preserving Treatment of Endometrial Carcinoma and Complex Atypical Hyperplasia in Young Women
    Zhou, Huimei
    Cao, Dongyan
    Yang, Jiaxin
    Shen, Keng
    Lang, Jinghe
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 (06) : 1167 - 1171
  • [40] Serum levonorgestrel levels and endometrial thickness during extended use of the levonorgestrel-releasing intrauterine system
    Hidalgo, Maria M.
    Hidalgo-Regina, Creusa
    Bahamondes, M. Valeria
    Monteiro, Ilza
    Petta, Carlos A.
    Bahamondes, Luis
    CONTRACEPTION, 2009, 80 (01) : 84 - 89
12345